NDC 68071-3892-01 - Telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3892
- Requested NDC
- 68071-3892-01
- Package NDCs from labels
- 68071-3892-1, 68071-3892-01
- Manufacturer
- NuCare Pharmaceuticals, Inc.
- Effective date
- 2025-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan - NuCare Pharmaceuticals, Inc. | NuCare Pharmaceuticals, Inc. | 2025-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3892-1 | Telmisartan | 100 in 1 BOTTLE | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | f13e0919-5ee2-4855-b7c8-c8ab423769dd | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Lifestar Pharma LLC | 3ff464e6-7a36-4544-a06f-7848414f77fc | 2024-10-18 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| telmisartan | TELMISARTAN | Zydus Lifesciences Limited | 2e3cc412-fa44-4304-aabc-d6e412f81fbf | 2024-08-12 | 205304 282755 205305 U5SYW473RQ | |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | NuCare Pharmaceuticals,Inc. | a020e2a7-d1e7-8ae0-e053-2995a90abad3 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Aurobindo Pharma Limited | fef6532d-438a-435e-a61f-216dd8551339 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Lupin Pharmaceuticals, Inc. | a97fefa6-99e6-4eb7-9393-ab2252a2c7d8 | 2023-12-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Zydus Pharmaceuticals USA Inc. | e61c209a-4fc3-4f5c-b526-6412f0b8897c | 2023-11-08 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals LLC | 20a60231-64f0-4751-aa81-6c0e64334179 | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Modavar Pharmaceuticals LLC | a075633a-2a2a-4e88-8ede-b49a3920a16c | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | A-S Medication Solutions | 509cd338-24db-41d1-a115-9dc999170717 | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan | TELMISARTAN | Cadila Pharmaceuticals Limited | 353fcb30-2fa7-4ff1-8a18-26f3ec279d00 | 2023-08-02 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals of New York LLC | bf2dca37-ce9c-40e4-8ad6-b8186aa7fed1 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan | TELMISARTAN | Mylan Pharmaceuticals Inc. | c3658bc8-1524-43db-930e-66f9ac01b808 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.